FDA Inspection
3M Company3M Company – FDA Inspection, Mar 20, 2020
Record Details
This FDA Inspection record concerns 3M Company, with an inspection on March 20, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- 3M Company
- Inspection Date
- March 20, 2020
- Product Type
- Drugs
View Company Profile
ID · 544c3c70-01af-4b48-9d48-3fab9802c765
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1123567
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.150Written distribution procedure
Full citation text and observation details available on the Dashboard.
Other FDA inspections of 3M Company
5| Date | Classification | Office | Project area |
|---|---|---|---|
| October 19, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 15, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 18, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 30, 2009 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for 3M Company
- FDA Inspection 1075144 - 2018-10-19
- FDA Inspection 907895 - 2014-12-15
- FDA Inspection 828412 - 2013-04-18
- FDA Inspection 778370 - 2012-04-20
- FDA Inspection 634005 - 2009-10-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.